Skip to content
MarketScale
Demo
‹ Back to IndustriesHealthcare

Carnival Cruise Bookings Nearly Double After Covid Curbs Eased

(Bloomberg) — Carnival Corp. shares rose as much as 4.1% after the cruise company’s flagship division reported a surge in bookings following the lifting of some Covid-19 restrictions. Carnival Cruise Line said bookings on Monday were “nearly double” the level for the same day in 2019 after management eliminated pre-cruise testing requirements for vaccinated guests…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Carnival Cruise Bookings Nearly Double After Covid Curbs Eased

(Bloomberg) — Carnival Corp. shares rose as much as 4.1% after the cruise company’s flagship division reported a surge in bookings following the lifting of some Covid-19 restrictions.

Carnival Cruise Line said bookings on Monday were “nearly double” the level for the same day in 2019 after management eliminated pre-cruise testing requirements for vaccinated guests and the exemption request process for people who aren’t vaccinated.

“Our guests are booking the remaining 2022 inventory, and getting a head start planning for 2023,” Carnival President Christine Duffy said in a statement. “Mid-August is typically not a busy month for cruise bookings, but it’s clear that pent-up demand for Carnival has not been satisfied and guests are responding very favorably to our updated protocols.”

Carnival shares rose as high as $11.15 in New York. They were up 3.2% to $11.05 at 12:53 p.m. Royal Caribbean Cruises Ltd. and Norwegian Cruise Line Holdings Ltd. also rose.

More stories like this are available on bloomberg.com

©2022 Bloomberg L.P.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For Healthcare teams

See how Healthcare teams use MarketScale →

Executive Thought Leadership

Explore Channels

Industry news, analysis, and expert perspectives

Professional AV›Engineering & Construction›Education Technology›Healthcare›Energy›Software & Technology›Retail›Business Services›Industrial IoT›Sports & Entertainment›Transportation›Sciences›Building Management›Food & Beverage›Architecture & Design›Hospitality›
Keep exploring

More from Healthcare

Healthcare hubMore expert Healthcare coverage.Explore →Executive Thought LeadershipPut clinical leaders on the record.Explore →CooperVisionMedical device storytelling.Explore →State of GEO & AI VisibilityHow B2B brands get cited by AI search.Explore →

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512